Global Remote Clinical Trials Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Remote Clinical Trials Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The FDA defines remote clinical trials as those executed through telemedicine and mobile/local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Remote Clinical Trials report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Remote Clinical Trials market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Oncology and Cardiovascular are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Remote Clinical Trials industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Remote Clinical Trials key companies include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health and Clinical Ink, etc. Medidata, IQVIA, Labcorp are top 3 players and held % share in total in 2022.
Remote Clinical Trials can be divided into Interventional, Observational and Expanded Access,, etc. Interventional is the mainstream product in the market, accounting for % share globally in 2022.
Remote Clinical Trials is widely used in various fields, such as Oncology, Cardiovascular and Others,, etc. Oncology provides greatest supports to the Remote Clinical Trials industry development. In 2022, global % share of Remote Clinical Trials went into Oncology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Remote Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Segment by Type
Interventional
Observational
Expanded Access
Oncology
Cardiovascular
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Remote Clinical Trials market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Remote Clinical Trials introduction, etc. Remote Clinical Trials Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Remote Clinical Trials market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Remote Clinical Trials report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Remote Clinical Trials market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Oncology and Cardiovascular are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Remote Clinical Trials industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Remote Clinical Trials key companies include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health and Clinical Ink, etc. Medidata, IQVIA, Labcorp are top 3 players and held % share in total in 2022.
Remote Clinical Trials can be divided into Interventional, Observational and Expanded Access,, etc. Interventional is the mainstream product in the market, accounting for % share globally in 2022.
Remote Clinical Trials is widely used in various fields, such as Oncology, Cardiovascular and Others,, etc. Oncology provides greatest supports to the Remote Clinical Trials industry development. In 2022, global % share of Remote Clinical Trials went into Oncology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Remote Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Segment by Type
Interventional
Observational
Expanded Access
Segment by Application
Oncology
Cardiovascular
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Remote Clinical Trials market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Remote Clinical Trials introduction, etc. Remote Clinical Trials Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Remote Clinical Trials market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices